Generic Name and Formulations:
Cyproheptadine HCl 4mg; scored tabs.
Various generic manufacturers
Indications for Cyproheptadine:
Allergic and vasomotor rhinitis, conjunctivitis, urticaria, angioedema, reactions to blood. Adjunct in anaphylaxis. Cold urticaria. Dermatographism.
≥14yrs: initially 4mg 3 times daily; usual range 12–16mg/day; max 0.5mg/kg per day.
<2yrs: not recommended. 2–6yrs: 2mg 2–3 times per day; max 12mg daily. 7–14yrs: 4mg 2–3 times per day; max 16mg daily.
MAOIs. Glaucoma. GI or urinary obstruction. Elderly. Debilitated. Neonates. Premature infants. Nursing mothers.
Hyperthyroidism. Cardiovascular disease. Hypertension. Increased intraocular pressure. History of asthma. Pregnancy (Cat.B).
See Contraindications. Anticholinergic effects potentiated by MAOIs. Potentiates CNS depression with alcohol, other CNS depressants.
Drowsiness, dizziness, paradoxical excitement, anticholinergic effects, gastritis, hypotension, blood dyscrasias.
Formerly known under the brand name Periactin.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Mood Stabilizers Associated With Increased Risk for Stroke in Bipolar Disorder
- Patients With Schizophrenia May Benefit From Occupational Therapy
- FDA Committees Vote on Opioid System Modulator for MDD Treatment
- Minocycline vs Routine Care for Clinical Symptom Improvement in Schizophrenia
- Methylphenidate for ADHD Treatment May Be Associated With Low BMI
- Cardioprotective Treatment May Reduce Adverse Effects in Schizophrenia
- Opioid Use Often Persists in Workers' Compensation Claimants
- Parental Mental Disorders Linked to Work Disabilities in Offspring
- Insomnia in Borderline Personality Disorder May Increase Suicide Risk
- Mortality Rates in Parkinson Disease Psychosis With Pimavanserin, Quetiapine